Lan Tang

Title: Innovations by Lan Tang in Diabetes Research

Introduction

Lan Tang is an innovative inventor based in Toronto, Canada. He has made significant contributions to the field of diabetes research through his patented work. His research focuses on the intricate relationship between neuropeptides and insulin sensitivity, which has implications for both Type 1 and Type 2 diabetes.

Latest Patents

Lan Tang holds a patent for a process that controls inflammatory tissue access through the release of neuropeptides, such as substance P (sP), to insulin-responsive sensory neurons. This innovative approach aims to simultaneously manage insulin sensitivity and resistance. In his research, he highlights the fundamental roles of sensory afferents, particularly TRPV1, in insulin/glucose homeostasis, islet physiology, and autoimmune tissue inflammation. By manipulating the TRPV1 neuro-β-cell circuit or enhancing pancreatic sP levels, his work aims to normalize insulin resistance, clear inflammation, and prevent both Type 1 and Type 2 diabetes.

Career Highlights

Lan Tang is affiliated with The Hospital for Sick Children, where he conducts his research. His work has garnered attention for its potential to transform diabetes treatment and management.

Collaborations

Lan collaborates with notable colleagues, including Hans-Michael Dosch and Yin Chan, who contribute to his research efforts.

Conclusion

Lan Tang's innovative research and patent in the field of diabetes highlight the importance of neuropeptides in managing insulin sensitivity and resistance. His contributions have the potential to significantly impact the treatment of diabetes.